Whitney Johnson
General Practice · Grapevine, TXNPI 1871575241
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $884, 2.2 times the $393 reported in 2021. Among general practice clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $23.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$561
- Mayne Pharma Commercial LLC$434
- Exeltis, USA Inc.$286
- Astellas Pharma US Inc$258
- Dexcom, Inc.$167
- Millicent US Inc$123
- plus $757 from 19 others
What the payments were for
- Food & beverage$2,48696%
- Education$994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $561 |
| Mayne Pharma Commercial LLC | 16 | $434 |
| Exeltis, USA Inc. | 9 | $286 |
| Astellas Pharma US Inc | 5 | $258 |
| Dexcom, Inc. | 3 | $167 |
| Millicent US Inc | 6 | $123 |
| Myovant Sciences Inc. | 4 | $80 |
| Shield Therapeutics Inc | 2 | $77 |
| Agile Therapeutics, Inc. | 3 | $59 |
| Biogen | 2 | $56 |
| Therapeuticsmd, Inc. | 4 | $56 |
| Evofem Biosciences, Inc. | 2 | $47 |
| Johnson & Johnson | 1 | $44 |
| Bayer | 2 | $44 |
| Axonics, Inc. | 2 | $42 |
| Pfizer | 2 | $42 |
| Virtus Pharmaceuticals LLC | 2 | $41 |
| Exact Sciences | 1 | $29 |
| Endo Pharmaceuticals Inc. | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Merck | 1 | $20 |
| Bausch Health US, LLC | 1 | $18 |
| Avion Pharmaceuticals | 1 | $15 |
| Channel Medsystems, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Twirla$183
- Slynd$183
- ANNOVERA$122
- NEXTSTELLIS$122
- DEXCOM G7 GSS (161)$122
- DEXCOM STELO GLUCOSE BIOSENSOR$122
- Veozah$112
- ORIAHNN$111
How this compares
$2,585 in reported general payments places this provider in the 90th percentile of 8,074 general practice providers in Texas.
Other general practice in Grapevine
- Marcus LastimadoFort Bliss$2.3M
- Christina DeanFrisco$1.9M
- Paul ShrodeMissouri City$1.2M
- Alan DouglasSan Antonio$609K
- C Mike MeekAustin$509K
- Young KwonDallas$288K
- Matthew HicksFriendswood$268K
- Kathleen Szelei-StevensHouston$253K
- Hoa TranPearland$156K
- Mitchell KimRichardson$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.